心血管

订阅

MedSci主页 / 所有栏目 / 心血管

AACE血脂异常管理与动脉粥样硬化预防指南解读

2012-05-17 美国临床内分泌医师学会 美国临床内分泌医师学会

AACE血脂异常指南解读
关注

AACE血脂异常管理和动脉粥样硬化预防指南解读.doc 出处： Endocr pract 2012;18(Suppl) 作者： 广西医科大学第五附院，柳州市人民医院心内科胡世红

AACE血脂异常管理和动脉粥样硬化预防指南解读.doc 出处： Endocr pract 2012;18(Suppl) 作者： 广西医科大学第五附院，柳州市人民医院心内科胡世红

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-09-23 shanyongle

    #ACE#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-08-24 xugumin

    #血脂异常管理#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-09-18 zgwhgch

    #AACE#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2013-02-15 huangshifeng

    #粥样硬化#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-05-19 bugit

    #血脂异常#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1655651, encodeId=199816556513f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Sep 23 07:23:00 CST 2012, time=2012-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774534, encodeId=05eb1e745345e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Aug 24 23:23:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699173, encodeId=070516991e3b6, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Tue Sep 18 04:23:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944331, encodeId=cacf194433128, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Feb 15 06:23:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253694, encodeId=18cd125369428, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551719, encodeId=9ccd1551e19f1, content=<a href='/topic/show?id=305156401eb' target=_blank style='color:#2F92EE;'>#指南解读#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56401, encryptionId=305156401eb, topicName=指南解读)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb0214221999, createdName=shuangle, createdTime=Sat May 19 11:23:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-05-19 shuangle

    #指南解读#

    0

相关资讯

AACE绝经后骨质疏松诊治指南

　　骨质疏松是一种日益增多的严重性公共健康问题，并且可对医疗、社会和经济产生影响。此项指南由美国临床内分泌医师学会（AACE）制定[Endocr Pract. 2010；16（Suppl 3）]，并且希望以此降低骨质疏松相关性骨折风险，进而改善骨质疏松患者的生活质量。此项指南采用了最佳证据，并将疾病的经济影响以及绝经后骨质疏松女性的有效评估和治疗需求纳入考量范围。此项